Owens & Minor ROE 2010-2025 | OMI

Current and historical return on equity (ROE) values for Owens & Minor (OMI) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Owens & Minor ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $-0.37B $0.57B -50.60%
2024-12-31 $-0.36B $0.59B -45.14%
2024-09-30 $-0.05B $0.88B -5.51%
2024-06-30 $-0.04B $0.86B -4.71%
2024-03-31 $-0.04B $0.90B -4.22%
2023-12-31 $-0.04B $0.92B -4.41%
2023-09-30 $-0.12B $0.89B -12.70%
2023-06-30 $-0.10B $0.90B -10.50%
2023-03-31 $-0.04B $0.92B -4.32%
2022-12-31 $0.02B $0.95B 2.30%
2022-09-30 $0.12B $0.97B 12.80%
2022-06-30 $0.15B $0.96B 16.50%
2022-03-31 $0.19B $0.95B 21.09%
2021-12-31 $0.22B $0.94B 25.66%
2021-09-30 $0.23B $0.89B 28.58%
2021-06-30 $0.23B $0.85B 33.32%
2021-03-31 $0.11B $0.79B 18.94%
2020-12-31 $0.03B $0.71B 6.08%
2020-09-30 $-0.06B $0.45B -13.92%
2020-06-30 $-0.11B $0.40B -23.81%
2020-03-31 $-0.06B $0.42B -12.65%
2019-12-31 $-0.06B $0.46B -12.70%
2019-09-30 $-0.28B $0.49B -56.57%
2019-06-30 $-0.29B $0.50B -49.55%
2019-03-31 $-0.46B $0.50B -70.24%
2018-12-31 $-0.44B $0.52B -55.83%
2018-09-30 $-0.15B $0.79B -16.87%
2018-06-30 $-0.14B $0.80B -14.69%
2018-03-31 $0.06B $1.02B 6.15%
2017-12-31 $0.07B $1.02B 7.33%
2017-09-30 $0.08B $1.00B 7.84%
2017-06-30 $0.10B $0.99B 9.82%
2017-03-31 $0.10B $0.97B 10.53%
2016-12-31 $0.11B $0.96B 10.94%
2016-09-30 $0.11B $0.99B 11.35%
2016-06-30 $0.11B $1.00B 11.16%
2016-03-31 $0.11B $1.01B 10.91%
2015-12-31 $0.10B $0.99B 10.50%
2015-09-30 $0.09B $0.99B 8.67%
2015-06-30 $0.06B $0.98B 6.49%
2015-03-31 $0.06B $0.97B 6.00%
2014-12-31 $0.07B $0.99B 6.50%
2014-09-30 $0.08B $1.01B 7.81%
2014-06-30 $0.10B $1.03B 9.87%
2014-03-31 $0.11B $1.03B 10.85%
2013-12-31 $0.11B $1.03B 11.10%
2013-09-30 $0.11B $1.01B 10.94%
2013-06-30 $0.10B $0.99B 10.66%
2013-03-31 $0.11B $0.98B 10.88%
2012-12-31 $0.11B $0.97B 11.31%
2012-09-30 $0.11B $0.96B 11.37%
2012-06-30 $0.12B $0.95B 12.50%
2012-03-31 $0.12B $0.94B 12.58%
2011-12-31 $0.11B $0.92B 12.66%
2011-09-30 $0.11B $0.91B 12.65%
2011-06-30 $0.11B $0.90B 12.67%
2011-03-31 $0.11B $0.88B 12.97%
2010-12-31 $0.11B $0.86B 13.32%
2010-09-30 $0.12B $0.84B 15.05%
2010-06-30 $0.12B $0.82B 15.88%
2010-03-31 $0.12B $0.79B 15.75%
2009-12-31 $0.11B $0.77B 14.35%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.562B $10.701B
Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.851B 27.88
Boston Scientific (BSX) United States $151.436B 37.91
Stryker (SYK) United States $144.721B 30.26
EssilorLuxottica (ESLOY) France $129.653B 0.00
Medtronic (MDT) Ireland $110.247B 15.63
Lonza Group Ag (LZAGY) Switzerland $50.183B 0.00
Haleon (HLN) United Kingdom $47.171B 26.90
ResMed (RMD) United States $37.320B 28.03
Agilent Technologies (A) United States $32.988B 21.51
GE HealthCare Technologies (GEHC) United States $32.583B 15.47
Terumo (TRUMY) Japan $26.976B 35.04
Koninklijke Philips (PHG) Netherlands $21.839B 15.32
Insulet (PODD) United States $21.652B 84.99
Zimmer Biomet Holdings (ZBH) United States $18.103B 11.63
Baxter (BAX) United States $15.390B 11.49
Smith & Nephew SNATS (SNN) United Kingdom $12.776B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.410B 22.31
Lantheus Holdings (LNTH) United States $5.591B 14.10
Prestige Consumer Healthcare (PBH) United States $4.170B 18.63
Perrigo (PRGO) Ireland $3.636B 9.22
Haemonetics (HAE) United States $3.462B 15.77
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.203B 26.62
ICU Medical (ICUI) United States $3.152B 23.24
GN Store Nord (GNNDY) Denmark $2.272B 18.82
LeMaitre Vascular (LMAT) United States $1.884B 42.11
QuidelOrtho (QDEL) United States $1.870B 12.86
AtriCure (ATRC) United States $1.579B 0.00
Acuren (TIC) United States $1.283B 0.00
AdaptHealth (AHCO) United States $1.120B 11.37
Neogen (NEOG) United States $1.035B 13.25
Green Thumb Industries (GTBIF) United States $1.018B 22.91
BioLife Solutions (BLFS) United States $1.015B 0.00
Phibro Animal Health (PAHC) United States $0.991B 12.67
InMode (INMD) Israel $0.853B 8.59
Kestra Medical Technologies (KMTS) United States $0.822B 0.00
CeriBell (CBLL) United States $0.668B 0.00
Evolus (EOLS) United States $0.605B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.537B 0.00
Curaleaf Holdings (CURLF) Canada $0.514B 0.00
Valneva SE (VALN) France $0.476B 0.00
Surmodics (SRDX) United States $0.415B 0.00
Tilray Brands (TLRY) Canada $0.363B 0.00
Capricor Therapeutics (CAPR) United States $0.351B 0.00
SNDL (SNDL) Canada $0.326B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.86
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.287B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.23
Cerus (CERS) United States $0.256B 0.00
Sanara MedTech (SMTI) United States $0.247B 0.00
Quanterix (QTRX) United States $0.245B 0.00
ZimVie (ZIMV) United States $0.241B 10.95
OraSure Technologies (OSUR) United States $0.227B 0.00
Cresco Labs (CRLBF) United States $0.222B 0.00
Aurora Cannabis (ACB) Canada $0.220B 65.17
Biote (BTMD) United States $0.219B 6.17
Canopy Growth (CGC) Canada $0.219B 0.00
Brainsway (BWAY) Israel $0.217B 57.45
TriSalus Life Sciences (TLSI) United States $0.200B 0.00
Omeros (OMER) United States $0.187B 0.00
Utah Medical Products (UTMD) United States $0.178B 14.52
Verano Holdings (VRNOF) United States $0.177B 0.00
High Tide (HITI) Canada $0.175B 0.00
Organigram Global (OGI) Canada $0.171B 0.00
Exagen (XGN) United States $0.148B 0.00
Vireo Growth (VREOF) United States $0.131B 0.00
FitLife Brands (FTLF) United States $0.122B 15.02
Jin Medical (ZJYL) China $0.101B 0.00
Veru (VERU) United States $0.091B 0.00
Fonar (FONR) United States $0.088B 11.29
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.084B 0.00
MacroGenics (MGNX) United States $0.083B 0.00
Cytosorbents (CTSO) United States $0.079B 0.00
Apyx Medical (APYX) United States $0.076B 0.00
TerrAscend (TSNDF) Canada $0.076B 0.00
Zynex (ZYXI) United States $0.072B 0.00
InterCure (INCR) Israel $0.071B 0.00
Agape ATP (ATPC) $0.069B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Jushi Holdings (JUSHF) United States $0.054B 0.00
Nephros (NEPH) United States $0.045B 61.29
Modular Medical (MODD) United States $0.042B 0.00
United-Guardian (UG) United States $0.038B 13.03
Rockwell Medical (RMTI) United States $0.030B 0.00
Safety Shot (SHOT) United States $0.025B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.016B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00